You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 142 No. 11, November 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Diagnosis
 •Cardiovascular System
 •Cardiovascular Disease/ Myocardial Infarction
 •Hypersensitivity
 •Dermatologic Disorders, Other
 •Drug Therapy
 •Adverse Effects
 •Alert me on articles by topic

VIGNETTES
Leukocytoclastic Vasculitis Masquerading as Hand-Foot Syndrome in a Patient Treated With Sorafenib

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Report of a Case

A 70-year-old white man with metastatic non–small cell lung carcinoma developed discrete, painful, erythematous small plaques and bullae with dusky to violaceous centers on his fingertips approximately 25 days after starting treatment with oral sorafenib (BAY 43-9006), 400 mg twice daily. Several days later, similar targetlike lesions appeared on his palms, elbows, and the dorsal surface of his hands (Figure 1). In addition, large bullae developed on the soles of his feet. A skin biopsy specimen revealed fibrinoid necrosis of the walls of superficial dermal capillaries with surrounding leukocytolysis, dermal hemorrhage, and necrosis of the overlying epidermis, findings consistent with leukocytoclastic vasculitis (LCV) (Figure 2). Results of staining for bacteria, acid-fast bacilli, and fungi were negative. Findings of a workup for possible endocarditis, including transesophageal echocardiography and blood cultures, were negative. Assay results for antinuclear antibody, cytoplasmic antineutrophil cytoplasmic antibody, perinuclear antineutrophil cytoplasmic antibody, and cryoglobulins . . . [Full Text of this Article]


Comment

AUTHOR INFORMATION
Nancy M. Chung, MD; Martin Gutierrez, MD; Maria L. Turner, MD







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.